Protara Therapeutics, Inc. (TARA)
3.88
+0.03
(+0.78%)
USD |
NASDAQ |
Aug 24, 16:00
3.88
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Market Cap : 229.25M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 227.47M |
| August 20, 2026 | 230.43M |
| August 19, 2026 | 233.97M |
| August 18, 2026 | 235.15M |
| August 17, 2026 | 235.15M |
| August 14, 2026 | 234.56M |
| August 13, 2026 | 232.79M |
| August 12, 2026 | 229.84M |
| August 11, 2026 | 231.02M |
| August 10, 2026 | 242.83M |
| August 07, 2026 | 243.43M |
| August 06, 2026 | 242.24M |
| August 05, 2026 | 220.22M |
| August 04, 2026 | 220.77M |
| August 03, 2026 | 218.57M |
| July 31, 2026 | 215.82M |
| July 30, 2026 | 221.87M |
| July 29, 2026 | 209.76M |
| July 28, 2026 | 216.92M |
| July 27, 2026 | 222.42M |
| July 24, 2026 | 221.32M |
| July 23, 2026 | 222.42M |
| July 22, 2026 | 224.63M |
| July 21, 2026 | 225.18M |
| July 20, 2026 | 224.08M |
| Date | Value |
|---|---|
| July 17, 2026 | 225.73M |
| July 16, 2026 | 224.63M |
| July 15, 2026 | 226.83M |
| July 14, 2026 | 225.18M |
| July 13, 2026 | 230.13M |
| July 10, 2026 | 237.84M |
| July 09, 2026 | 231.23M |
| July 08, 2026 | 226.28M |
| July 07, 2026 | 235.09M |
| July 06, 2026 | 224.63M |
| July 02, 2026 | 223.53M |
| July 01, 2026 | 222.42M |
| June 30, 2026 | 210.31M |
| June 29, 2026 | 229.03M |
| June 26, 2026 | 226.83M |
| June 25, 2026 | 220.22M |
| June 24, 2026 | 221.87M |
| June 23, 2026 | 220.22M |
| June 22, 2026 | 226.28M |
| June 18, 2026 | 219.12M |
| June 17, 2026 | 224.08M |
| June 16, 2026 | 209.76M |
| June 15, 2026 | 216.92M |
| June 12, 2026 | 214.72M |
| June 11, 2026 | 200.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.4687M |
| Brainstorm Cell Therapeutics, Inc. | 10.81M |
| Summit Therapeutics, Inc. | 10.09B |
| Kezar Life Sciences, Inc. | 53.76M |
| Clene, Inc. | 56.67M |
Market Cap Related Metrics
| Price to Book Value | 1.421 |
| Price | 3.88 |
| Earnings Yield | -34.89% |